Impact of COVID-19:
The pandemic has severe impact on the world economy. It also affected the healthcare sector and had long-term impact on several other sectors. Many research projects and clinical trials were halted during the pandemic owing to the shortage of resources. Lockdowns were imposed in many regions, and people suffering from diseases other than COVID-19 had to face many challenges. As hospitals were already running on full capacity, several clinics were shut down and all doctors were deployed to treat COVID-19 patients. This hampered other treatment options. Diagnosis and treatment for cancer and other disease were either delayed or postponed. These patients were at a huge risk of getting infected with the virus so they were monitored remotely. This hampered the growth of the global cryotherapy market.
Cryotherapy is still only available in a small number of places. Cryotherapy is mostly practised in North America and Europe, and only a small number of other nations, including Japan, China, and Australia, have seen any breakthroughs in this area. This is largely owing to a lack of awareness in those countries. While being safer and less unpleasant than highly invasive surgical procedures, it is typically only used for extensive surgical treatments. The "International Patient Survey: Ledderhose disease" revealed that patients thought cryotherapy was a more efficient treatment choice than traditional ones, but that it was also less accessible.
Although Cryosurgery may be widely accessible for the treatment of cervical neoplasias, according to the US NIH National Cancer Institute, only a very small number of hospitals and cancer centres in the US have the necessary equipment to perform cryosurgery for other noncancerous, precancerous, and cancerous conditions. Throughout the foreseeable period, limited availability of Cryotherapy Market and a lack of knowledge about its advantages could limit market growth to some extent.
